DrugPatentWatch Database Preview
Vortioxetine hydrobromide - Generic Drug Details
see a sample report or, see our see our flat-rate plans
What are the generic sources for vortioxetine hydrobromide and what is the scope of vortioxetine hydrobromide freedom to operate?
Vortioxetine hydrobromide has one hundred and fifty-five patent family members in forty countries.
There are sixteen drug master file entries for vortioxetine hydrobromide. One supplier is listed for this compound.
Summary for vortioxetine hydrobromide
| International Patents: | 155 |
| US Patents: | 9 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 16 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 40 |
| Patent Applications: | 48 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for vortioxetine hydrobromide |
| DailyMed Link: | vortioxetine hydrobromide at DailyMed |
Synonyms for vortioxetine hydrobromide
| 1-(2-((2,4-Dimethylphenyl)sulfanyl)phenyl)piperazine monohydrobromide |
| 1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine hydrobromide |
| 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine-hbr |
| 1-[2-[(2,4-dimethylphenyl)thio]phenyl]piperazine hydrobromide |
| 1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine hydrobromide |
| 2796AH |
| 4-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]-piperazine hydrobromide |
| 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium bromide |
| 960203-27-4 |
| AB0165485 |
| AC-28325 |
| AKOS016340374 |
| Brintellix |
| Brintellix (TN) |
| C18H22N2S.BrH |
| CHEBI:76015 |
| CHEMBL2107387 |
| CS-1472 |
| D10185 |
| EBD3080710 |
| FT-0696676 |
| HG-0011 |
| HY-15414A |
| KB-81459 |
| Lu AA 21004 hydrobromide;Lu AA21004 hydrobromide |
| Lu AA 21004|||1-[2-[(2,4-dimethylphenyl)thio]phenyl]-piperazine hydrobromide |
| Lu AA21004 (HBr) |
| Lu-AA-21004 |
| Lu-AA21004-(HBr) |
| MFCD22383961 |
| MolPort-023-298-793 |
| Piperazine, 1-(2-((2,4-dimethylphenyl)thio)phenyl)-, hydrobromide (1:1) |
| s8021 |
| SC-95551 |
| SCHEMBL237653 |
| TKS641KOAY |
| Trintellix |
| UNII-TKS641KOAY |
| VNGRUFUIHGGOOM-UHFFFAOYSA-N |
| Vortioxetine (hydrobromide) |
| Vortioxetine (Lu AA21004) HBr |
| Vortioxetine (Lu AA21004) hydrobromide |
| Vortioxetine HBr |
| Vortioxetine hydrobromide (JAN/USAN) |
| Vortioxetine hydrobromide [USAN] |
| vortioxetine monohydrobromide |
| W-5911 |
US Patents and Regulatory Information for vortioxetine hydrobromide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | TRINTELLIX | vortioxetine hydrobromide | TABLET;ORAL | 204447-004 | Sep 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Takeda Pharms Usa | TRINTELLIX | vortioxetine hydrobromide | TABLET;ORAL | 204447-002 | Sep 30, 2013 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Takeda Pharms Usa | TRINTELLIX | vortioxetine hydrobromide | TABLET;ORAL | 204447-004 | Sep 30, 2013 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Takeda Pharms Usa | TRINTELLIX | vortioxetine hydrobromide | TABLET;ORAL | 204447-003 | Sep 30, 2013 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Non-Orange Book US Patents for vortioxetine hydrobromide
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,138,407 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | ➤ Sign Up |
| 7,148,238 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | ➤ Sign Up |
| 7,683,053 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | ➤ Sign Up |
| 8,110,567 | Phenyl-piperazine derivatives as serotonin reuptake inhibitors | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
see a sample report or, see our see our flat-rate plans
International Patents for vortioxetine hydrobromide
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1172014 | ➤ Sign Up |
| Cyprus | 1111183 | ➤ Sign Up |
| Eurasian Patent Organization | 017058 | ➤ Sign Up |
| European Patent Office | 2044043 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for vortioxetine hydrobromide
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 0140012 00108 | Estonia | ➤ Sign Up | PRODUCT NAME: VORTIOKSETIIN;REG NO/DATE: K(2013)9715 LOPLIK 20.12.2013 |
| 2014 00030 | Denmark | ➤ Sign Up | PRODUCT NAME: VORTIOXETIN ELLER FARMACEUTISK ACCEPTABLE SYREADDITIONSSALTE DERAF, HERUNDER VORTIOXETINHYDROBROMID; REG. NO/DATE: EU/1/13/891 20131218 |
| 397 | Luxembourg | ➤ Sign Up | PRODUCT NAME: VORTIOXETINE OU UN SEL D ADDITION D ACIDE DE CELUI-CI PHARMACEUTIQUEMENT ACCEPTABLE |
| 00652 | Netherlands | ➤ Sign Up | PRODUCT NAME: VORTIOXETINE OF EEN; REGISTRATION NO/DATE: EU/1/13/891/001-036 20131218 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
